Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail
Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Daniella Brasacchio 1 , Jun Okabe 1 , Christos Tikellis 2 , Aneta Balcerczyk 1 , Prince George 1 , Emma K. Baker 1 , Anna C. Cal...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 58; no. 5; pp. 1229 - 1236 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.05.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating
Epigenetic Marks That Coexist on the Lysine Tail
Daniella Brasacchio 1 ,
Jun Okabe 1 ,
Christos Tikellis 2 ,
Aneta Balcerczyk 1 ,
Prince George 1 ,
Emma K. Baker 1 ,
Anna C. Calkin 2 ,
Michael Brownlee 3 ,
Mark E. Cooper 2 , 3 and
Assam El-Osta 1
1 Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and
Diabetes Institute, Victoria, Australia;
2 Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker
IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia;
and
3 JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York.
Corresponding author: Assam El-Osta, assam.el-osta{at}bakeridi.edu.au .
Abstract
OBJECTIVE Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and
Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious
end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years
after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as “hyperglycemic
memory.” We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes
in epigenetic information.
RESEARCH DESIGN AND METHODS Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by
the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of
soluble NFκB-p65 chromatin.
RESULTS The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased
H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression
of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified
histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia.
CONCLUSIONS These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks
such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and
methyl-erasing histone enzymes.
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received December 2, 2008.
Accepted February 3, 2009.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work
is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
© 2009 by the American Diabetes Association. |
---|---|
AbstractList | Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information.OBJECTIVEResults from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information.Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin.RESEARCH DESIGN AND METHODSModels of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin.The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia.RESULTSThe sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia.These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes.CONCLUSIONSThese studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin. The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail Daniella Brasacchio 1 , Jun Okabe 1 , Christos Tikellis 2 , Aneta Balcerczyk 1 , Prince George 1 , Emma K. Baker 1 , Anna C. Calkin 2 , Michael Brownlee 3 , Mark E. Cooper 2 , 3 and Assam El-Osta 1 1 Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia; 2 Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and 3 JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York. Corresponding author: Assam El-Osta, assam.el-osta{at}bakeridi.edu.au . Abstract OBJECTIVE Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as “hyperglycemic memory.” We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. RESEARCH DESIGN AND METHODS Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFκB-p65 chromatin. RESULTS The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. CONCLUSIONS These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received December 2, 2008. Accepted February 3, 2009. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. © 2009 by the American Diabetes Association. OBJECTIVE--Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects cow tinued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. RESEARCH DESIGN AND METHODS--Models of transient hyperglycemia were used to link NFκB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demetho ylase (LSD1) by the immunopurification of soluble NFκBop65 chromatin. RESULTS--The sustained upregulation of the NFκB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4ml but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. CONCLUSIONS--These studies indicate that the active transcriptional state of the NFκB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more recently from the U.K. Prospective Diabetes Study (UKPDS) have revealed that the deleterious end-organ effects that occurred in both conventional and more aggressively treated subjects continued to operate >5 years after the patients had returned to usual glycemic control and is interpreted as a legacy of past glycemia known as "hyperglycemic memory." We have hypothesized that transient hyperglycemia mediates persistent gene-activating events attributed to changes in epigenetic information. Models of transient hyperglycemia were used to link NFkappaB-p65 gene expression with H3K4 and H3K9 modifications mediated by the histone methyltransferases (Set7 and SuV39h1) and the lysine-specific demethylase (LSD1) by the immunopurification of soluble NFkappaB-p65 chromatin. The sustained upregulation of the NFkappaB-p65 gene as a result of ambient or prior hyperglycemia was associated with increased H3K4m1 but not H3K4m2 or H3K4m3. Furthermore, glucose was shown to have other epigenetic effects, including the suppression of H3K9m2 and H3K9m3 methylation on the p65 promoter. Finally, there was increased recruitment of the recently identified histone demethylase LSD1 to the p65 promoter as a result of prior hyperglycemia. These studies indicate that the active transcriptional state of the NFkappaB-p65 gene is linked with persisting epigenetic marks such as enhanced H3K4 and reduced H3K9 methylation, which appear to occur as a result of effects of the methyl-writing and methyl-erasing histone enzymes. |
Audience | Professional |
Author | Assam El-Osta Christos Tikellis Emma K. Baker Anna C. Calkin Daniella Brasacchio Prince George Aneta Balcerczyk Jun Okabe Mark E. Cooper Michael Brownlee |
Author_xml | – sequence: 1 givenname: Daniella surname: Brasacchio fullname: Brasacchio, Daniella organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia – sequence: 2 givenname: Jun surname: Okabe fullname: Okabe, Jun organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia – sequence: 3 givenname: Christos surname: Tikellis fullname: Tikellis, Christos organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and – sequence: 4 givenname: Aneta surname: Balcerczyk fullname: Balcerczyk, Aneta organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia – sequence: 5 givenname: Prince surname: George fullname: George, Prince organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia – sequence: 6 givenname: Emma K. surname: Baker fullname: Baker, Emma K. organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia – sequence: 7 givenname: Anna C. surname: Calkin fullname: Calkin, Anna C. organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and – sequence: 8 givenname: Michael surname: Brownlee fullname: Brownlee, Michael organization: JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York – sequence: 9 givenname: Mark E. surname: Cooper fullname: Cooper, Mark E. organization: Junvenile Diabetes Research Foundation (JDRF) Danielle Alberti Centre for Diabetic Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia; and, JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, New York – sequence: 10 givenname: Assam surname: El-Osta fullname: El-Osta, Assam organization: Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker IDI Heart and Diabetes Institute, Victoria, Australia |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21457652$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19208907$$D View this record in MEDLINE/PubMed |
BookMark | eNp9k11v0zAUhiM0xD7ggj-ALBBICGXzR5vEN0hVN9ZJnXYzBHeW65ykHqldYncs_CX-JCdq6SiqkC-SOM953-Nzjo-TA-cdJMlLRk-5EPlZOaNFyrIse5IcMSlkKnj-9SA5opTxlOUyP0yOQ7ijlGa4niWHTHJaSJofJb8m3RLauukMLKwmV65cGQhEk_PO6YU1ZOw9Ajraexs74isysSGiPbmGOO8aHYBoV5JzWGy_L9zPboEioxC8sTpCSb7YOCeX4CAdGZRCOVeTi6WtcSuiy7VuvwVyO9cRDeEBLYh3JM6BTLtg0e1W2-Z58rTSTYAXm-dJ8vnTxe14kk5vLq_Go2lqsoGIqYEZlwY403wGlShoVvBqRplkhcmGnBUiG2rOZFbMYEjpoBzAUBjKBkYywSATJ8nHte5yNVtAacDFVjdq2dqFbjvltVW7f5ydq9rfK57ljIoCBd5tBFr_fQUhqoUNBppGO_CroBDLpeC90-t_wDu_ah0eTnGWDSTDNBF6s4Zq3YCyrvJoanpFNWJSDjIhC4FUuofq64sZYr8qi9s7_OkeHleJg2D2BrzfCUAmwkOs9SoEVVxO_5fMhjW-aaAGhd0a3-zyr_6u-LbUf-YUgbcbQAejm6rVztiw5TgbDHPsLXJna860PoQWKmVsxGnzfaNsoxhV_Y1R_Y1R_Y15PNY2Ymu-h_2wZue2nv-wLajS6hlECI8vw0INFeNcit9Y7CNF |
CODEN | DIAEAZ |
CitedBy_id | crossref_primary_10_1089_jir_2014_0172 crossref_primary_10_1016_j_freeradbiomed_2017_12_017 crossref_primary_10_1016_j_intimp_2024_111558 crossref_primary_10_1155_2017_2608605 crossref_primary_10_3390_cells10102548 crossref_primary_10_3390_genes13040705 crossref_primary_10_1161_JAHA_118_010012 crossref_primary_10_1093_cvr_cvac058 crossref_primary_10_1139_cjpp_2012_0251 crossref_primary_10_1016_j_smim_2016_04_004 crossref_primary_10_1093_nar_gkw621 crossref_primary_10_1172_JCI61084 crossref_primary_10_1002_dmrr_1281 crossref_primary_10_2337_db13_1251 crossref_primary_10_1002_dmrr_2375 crossref_primary_10_1146_annurev_immunol_102119_073855 crossref_primary_10_1016_j_biocel_2016_06_021 crossref_primary_10_1016_j_molonc_2012_07_004 crossref_primary_10_1016_j_atherosclerosis_2013_07_003 crossref_primary_10_1007_s11892_018_0979_3 crossref_primary_10_3390_ijms21228462 crossref_primary_10_1210_me_2013_1293 crossref_primary_10_1161_HYPERTENSIONAHA_114_04585 crossref_primary_10_3390_molecules23030567 crossref_primary_10_3389_fphys_2021_640700 crossref_primary_10_1016_j_diabres_2011_05_033 crossref_primary_10_1007_s00424_010_0807_3 crossref_primary_10_1681_ASN_0000000000000345 crossref_primary_10_1155_2014_654148 crossref_primary_10_1007_s11427_014_4710_6 crossref_primary_10_1007_s13679_022_00477_x crossref_primary_10_1002_dmrr_1037 crossref_primary_10_1038_labinvest_2013_47 crossref_primary_10_1097_MD_0000000000016317 crossref_primary_10_1161_CIRCRESAHA_116_303936 crossref_primary_10_3390_toxins10100410 crossref_primary_10_1016_j_neulet_2016_04_046 crossref_primary_10_1186_s12933_024_02196_0 crossref_primary_10_3390_nu8080486 crossref_primary_10_1038_s41598_018_34612_3 crossref_primary_10_2337_db12_1648 crossref_primary_10_3390_ijms21176275 crossref_primary_10_1016_j_bbadis_2018_09_032 crossref_primary_10_1161_CIRCRESAHA_115_306341 crossref_primary_10_1186_ar4564 crossref_primary_10_1210_me_2011_1157 crossref_primary_10_1016_j_canlet_2016_02_006 crossref_primary_10_1016_j_pharmthera_2010_10_003 crossref_primary_10_1155_2021_7887426 crossref_primary_10_1016_j_diabres_2014_03_019 crossref_primary_10_1016_j_mce_2013_04_002 crossref_primary_10_1016_j_xkme_2020_10_005 crossref_primary_10_3389_fcell_2021_777258 crossref_primary_10_1016_j_dsx_2018_07_001 crossref_primary_10_1080_15592294_2016_1278097 crossref_primary_10_2337_dbi18_0010 crossref_primary_10_1042_CS20120413 crossref_primary_10_1186_s13148_015_0090_4 crossref_primary_10_1155_2013_589474 crossref_primary_10_1017_S0954422411000102 crossref_primary_10_1515_hmbci_2016_0022 crossref_primary_10_1586_eem_10_76 crossref_primary_10_1016_S1957_2557_15_30008_0 crossref_primary_10_1093_cvr_cvr024 crossref_primary_10_2174_1573399818666220422085016 crossref_primary_10_1161_CIRCRESAHA_112_268375 crossref_primary_10_1186_s13148_020_00826_4 crossref_primary_10_3727_096368914X682792 crossref_primary_10_2174_0115733998279869231227091944 crossref_primary_10_1007_s00018_013_1299_z crossref_primary_10_1155_2010_437809 crossref_primary_10_1155_2020_3818196 crossref_primary_10_3390_nu14020320 crossref_primary_10_2337_db17_0294 crossref_primary_10_1016_j_bcp_2010_06_005 crossref_primary_10_1210_en_2013_1097 crossref_primary_10_1371_journal_pone_0123987 crossref_primary_10_1007_s00005_014_0271_4 crossref_primary_10_3390_ijms23094589 crossref_primary_10_1007_s12015_012_9398_z crossref_primary_10_1016_j_yjmcc_2019_06_010 crossref_primary_10_1007_s00246_019_02160_w crossref_primary_10_1038_nrendo_2010_188 crossref_primary_10_1089_ars_2015_6372 crossref_primary_10_3390_nu15040811 crossref_primary_10_1038_srep00081 crossref_primary_10_3389_fcell_2022_839109 crossref_primary_10_3390_ijms222111857 crossref_primary_10_1161_CIRCULATIONAHA_111_033274 crossref_primary_10_1681_ASN_2014070678 crossref_primary_10_1007_s11356_023_25236_w crossref_primary_10_1089_ars_2017_7347 crossref_primary_10_1038_pr_2013_224 crossref_primary_10_3390_ijms20194873 crossref_primary_10_1038_jhg_2013_57 crossref_primary_10_1016_j_tem_2016_09_003 crossref_primary_10_3390_biom11121779 crossref_primary_10_1042_CS20150093 crossref_primary_10_1016_j_gene_2012_09_090 crossref_primary_10_1111_febs_12938 crossref_primary_10_1016_S2213_8587_14_70155_X crossref_primary_10_2337_dbi20_0030 crossref_primary_10_2217_pme_15_17 crossref_primary_10_1016_j_biochi_2020_01_007 crossref_primary_10_1016_j_isci_2023_106917 crossref_primary_10_1016_j_krcp_2012_07_004 crossref_primary_10_1113_JP271913 crossref_primary_10_1155_2012_481840 crossref_primary_10_1530_JOE_15_0469 crossref_primary_10_1038_s41598_021_81794_4 crossref_primary_10_3390_jcm11123369 crossref_primary_10_3109_07853890_2013_857259 crossref_primary_10_26508_lsa_202302382 crossref_primary_10_1007_s00125_017_4490_1 crossref_primary_10_3389_fimmu_2020_00315 crossref_primary_10_1097_MCO_0b013e328338aa61 crossref_primary_10_1517_14728222_2011_561786 crossref_primary_10_4137_GEG_S12270 crossref_primary_10_3390_ijms19051456 crossref_primary_10_3892_mmr_2018_9142 crossref_primary_10_3945_ajcn_110_000927 crossref_primary_10_1016_j_yjmcc_2021_05_018 crossref_primary_10_2337_db16_0254 crossref_primary_10_1016_j_biochi_2022_08_001 crossref_primary_10_1074_jbc_M111_330373 crossref_primary_10_1016_j_vaccine_2021_04_011 crossref_primary_10_1021_cb500785t crossref_primary_10_1016_j_bbrc_2020_05_075 crossref_primary_10_1155_2021_5544518 crossref_primary_10_2337_db11_0588 crossref_primary_10_3389_fendo_2021_679655 crossref_primary_10_3389_fendo_2023_1119765 crossref_primary_10_1016_j_urolonc_2024_09_007 crossref_primary_10_1038_ki_2010_335 crossref_primary_10_1002_glia_22405 crossref_primary_10_1155_2016_4065382 crossref_primary_10_1016_j_bbrc_2013_02_064 crossref_primary_10_2478_fzm_2022_0030 crossref_primary_10_1007_s11428_023_01020_9 crossref_primary_10_1038_ncomms1755 crossref_primary_10_1152_ajprenal_00697_2012 crossref_primary_10_1159_000357824 crossref_primary_10_3390_biomedicines9111596 crossref_primary_10_1089_scd_2013_0125 crossref_primary_10_1007_s11892_017_0916_x crossref_primary_10_1016_j_jdiacomp_2015_07_015 crossref_primary_10_1007_s10719_021_10031_x crossref_primary_10_3390_nu9050437 crossref_primary_10_1007_s11356_021_13862_1 crossref_primary_10_1016_S2213_8587_21_00245_X crossref_primary_10_1042_BCJ20160595 crossref_primary_10_1016_j_jdiacomp_2018_08_012 crossref_primary_10_2353_ajpath_2010_090528 crossref_primary_10_1186_1475_2840_12_96 crossref_primary_10_1186_s13148_024_01667_1 crossref_primary_10_1007_s12041_013_0288_1 crossref_primary_10_1186_s13148_019_0632_2 crossref_primary_10_1177_1479164113500680 crossref_primary_10_1371_journal_pone_0109663 crossref_primary_10_3109_0886022X_2014_1000801 crossref_primary_10_3389_fcvm_2020_570553 crossref_primary_10_1038_s41573_019_0025_4 crossref_primary_10_1101_gr_116095_110 crossref_primary_10_1016_j_bbrc_2012_07_105 crossref_primary_10_1038_cdd_2016_119 crossref_primary_10_1097_FJC_0000000000001516 crossref_primary_10_1152_ajprenal_00237_2010 crossref_primary_10_1097_CM9_0000000000001450 crossref_primary_10_1002_cmdc_201402091 crossref_primary_10_3390_ijms19124061 crossref_primary_10_4093_dmj_2014_38_5_330 crossref_primary_10_1097_MOL_0b013e32834f319d crossref_primary_10_1038_nature12752 crossref_primary_10_1007_s00592_019_01363_0 crossref_primary_10_1016_j_pbiomolbio_2015_02_010 crossref_primary_10_1139_bcb_2015_0057 crossref_primary_10_1053_j_jvca_2016_02_008 crossref_primary_10_1155_2010_263914 crossref_primary_10_3389_fendo_2018_00002 crossref_primary_10_1007_s00018_016_2316_9 crossref_primary_10_1007_s12016_016_8592_1 crossref_primary_10_1016_j_clim_2014_12_013 crossref_primary_10_1096_fj_201901358RR crossref_primary_10_1016_j_biocel_2014_04_014 crossref_primary_10_17343_sdutfd_1273169 crossref_primary_10_1146_annurev_nutr_121214_104422 crossref_primary_10_1038_nrdp_2015_18 crossref_primary_10_2337_db10_0133 crossref_primary_10_31083_j_fbl2809194 crossref_primary_10_30629_0023_2149_2024_102_2_109_117 crossref_primary_10_1007_s12265_012_9380_9 crossref_primary_10_1038_s42003_022_03225_y crossref_primary_10_3389_fendo_2023_1128622 crossref_primary_10_1152_physrev_00045_2011 crossref_primary_10_3389_fphys_2022_952445 crossref_primary_10_2337_db09_1003 crossref_primary_10_1021_jm501234a crossref_primary_10_2337_db11_0416 crossref_primary_10_1038_s41581_019_0135_6 crossref_primary_10_1155_2017_9702820 crossref_primary_10_1038_nrendo_2014_29 crossref_primary_10_1042_BSR20202160 crossref_primary_10_3389_fphar_2022_885527 crossref_primary_10_1089_ars_2017_7310 crossref_primary_10_1016_j_tem_2014_08_006 crossref_primary_10_3390_biomedicines12091958 crossref_primary_10_1089_ars_2017_7318 crossref_primary_10_1007_s00125_014_3462_y crossref_primary_10_1681_ASN_2010060633 crossref_primary_10_1126_science_aaf1098 crossref_primary_10_1186_s13148_015_0068_2 crossref_primary_10_1161_CIRCULATIONAHA_111_025270 crossref_primary_10_3389_fimmu_2023_1183066 crossref_primary_10_3945_an_113_004705 crossref_primary_10_1152_physrev_00031_2021 crossref_primary_10_1038_icb_2014_105 crossref_primary_10_3390_ijms20122949 crossref_primary_10_1152_ajpcell_00011_2020 crossref_primary_10_1016_j_bbrc_2015_10_030 crossref_primary_10_1038_ki_2011_39 crossref_primary_10_1016_j_chom_2010_02_005 crossref_primary_10_1177_09636897231198167 crossref_primary_10_1111_1753_0407_13372 crossref_primary_10_3390_genes6010087 crossref_primary_10_1152_ajpendo_00105_2011 crossref_primary_10_3390_ijms222413378 crossref_primary_10_1016_j_dsx_2016_08_007 crossref_primary_10_3389_fimmu_2022_883410 crossref_primary_10_1007_s40618_014_0172_8 crossref_primary_10_1007_s00018_017_2635_5 crossref_primary_10_1152_ajprenal_00115_2024 crossref_primary_10_1016_j_semcancer_2020_11_019 crossref_primary_10_1155_2015_409432 crossref_primary_10_1186_s43042_024_00595_2 crossref_primary_10_1194_jlr_M002782 crossref_primary_10_4103_jpbs_JPBS_771_20 crossref_primary_10_1007_s10741_013_9381_z crossref_primary_10_1080_14728222_2019_1696309 crossref_primary_10_1016_j_bcp_2010_07_029 crossref_primary_10_1097_MED_0b013e328339f31e crossref_primary_10_1007_s11859_013_0886_z crossref_primary_10_1371_journal_pone_0135218 crossref_primary_10_1016_j_lfs_2022_120490 crossref_primary_10_1152_ajpcell_00201_2022 crossref_primary_10_1155_2016_6927234 crossref_primary_10_1007_s00125_010_1967_6 crossref_primary_10_1080_00325481_2019_1681215 crossref_primary_10_1093_eurheartj_ehaa857 crossref_primary_10_1172_JCI72271 crossref_primary_10_3109_10715762_2013_789136 crossref_primary_10_1089_ars_2011_4381 crossref_primary_10_3389_fimmu_2020_631743 crossref_primary_10_1161_HYPERTENSIONAHA_123_22483 crossref_primary_10_1371_journal_pone_0233639 crossref_primary_10_3389_fimmu_2019_01330 crossref_primary_10_1515_cclm_2017_0982 crossref_primary_10_1016_j_ajpath_2015_05_003 crossref_primary_10_1016_j_cmet_2010_09_004 crossref_primary_10_3390_ijms21051835 crossref_primary_10_1007_s11892_015_0677_3 crossref_primary_10_4161_epi_6_7_16551 crossref_primary_10_1002_mnfr_201900480 crossref_primary_10_1155_2018_2931049 crossref_primary_10_1016_j_pharmthera_2014_01_003 crossref_primary_10_1038_nrneph_2010_55 crossref_primary_10_1016_j_atherosclerosis_2017_09_003 crossref_primary_10_1016_j_chembiol_2010_11_014 crossref_primary_10_1016_j_ctrv_2018_08_004 crossref_primary_10_1155_2017_2712751 crossref_primary_10_2147_DMSO_S288500 crossref_primary_10_3389_fphar_2019_00666 crossref_primary_10_1007_s00018_018_2864_2 crossref_primary_10_1093_burnst_tkac057 crossref_primary_10_1016_j_molmet_2020_01_019 crossref_primary_10_1016_j_nut_2014_07_017 crossref_primary_10_1007_s00441_017_2588_x crossref_primary_10_1111_jcmm_18158 crossref_primary_10_3390_jcm8091329 crossref_primary_10_1007_s11684_021_0881_2 crossref_primary_10_1161_CIRCRESAHA_112_266171 crossref_primary_10_1016_j_cell_2017_12_013 crossref_primary_10_2217_pme_2017_0043 crossref_primary_10_1016_j_hlc_2010_07_013 crossref_primary_10_1155_2015_436879 crossref_primary_10_1007_s00018_014_1651_y crossref_primary_10_1016_j_jhep_2011_10_018 crossref_primary_10_1007_s12016_016_8534_y crossref_primary_10_1016_j_mam_2012_06_010 crossref_primary_10_2337_db14_0238 crossref_primary_10_1016_j_atherosclerosis_2016_12_007 crossref_primary_10_1152_physrev_00004_2012 crossref_primary_10_2337_db10_0208 crossref_primary_10_17795_jpr_3375 crossref_primary_10_1186_1868_7083_5_15 crossref_primary_10_2337_db11_0073 crossref_primary_10_2337_db14_0231 crossref_primary_10_1186_s40001_024_02069_y crossref_primary_10_21886_2712_8156_2022_3_2_7_18 crossref_primary_10_1007_s11892_012_0302_7 crossref_primary_10_1111_j_1440_1681_2011_05497_x crossref_primary_10_1016_j_semnephrol_2010_07_004 crossref_primary_10_1098_rsob_120173 crossref_primary_10_1016_j_fertnstert_2013_11_033 crossref_primary_10_3390_ijms19041224 crossref_primary_10_1161_CIRCRESAHA_110_223552 crossref_primary_10_1016_j_trsl_2017_05_002 crossref_primary_10_1152_ajprenal_00200_2010 crossref_primary_10_3389_fgene_2022_957937 crossref_primary_10_1002_biof_1306 crossref_primary_10_3390_antiox10111849 crossref_primary_10_1016_j_cmet_2017_02_006 crossref_primary_10_1016_j_mam_2016_09_004 crossref_primary_10_1080_15592294_2020_1748918 crossref_primary_10_4239_wjd_v12_i8_1200 crossref_primary_10_1152_ajprenal_00029_2017 crossref_primary_10_1096_fj_201601116R crossref_primary_10_1161_CIRCRESAHA_110_223545 crossref_primary_10_1155_2015_373708 crossref_primary_10_1161_CIRCRESAHA_116_306819 crossref_primary_10_1016_j_cmet_2011_11_007 crossref_primary_10_1016_j_survophthal_2020_02_005 crossref_primary_10_1517_14712598_2012_641531 crossref_primary_10_1186_s13148_025_01842_y crossref_primary_10_1016_j_jash_2010_02_004 crossref_primary_10_1038_s41419_020_2350_2 crossref_primary_10_1053_j_ackd_2014_03_004 crossref_primary_10_2337_db12_1141 crossref_primary_10_1016_j_ecl_2016_07_001 crossref_primary_10_1016_j_carpath_2012_07_004 crossref_primary_10_1007_s11892_016_0723_9 crossref_primary_10_1016_j_drudis_2023_103754 crossref_primary_10_1038_nrd3674 crossref_primary_10_3389_fcvm_2023_1164499 crossref_primary_10_1016_j_smim_2016_09_002 crossref_primary_10_1007_s00467_010_1714_8 crossref_primary_10_1586_eem_09_54 crossref_primary_10_1371_journal_pone_0154939 crossref_primary_10_1007_s10787_019_00663_9 crossref_primary_10_1155_2014_789120 crossref_primary_10_1007_s11892_013_0383_y crossref_primary_10_1016_j_imbio_2016_08_011 crossref_primary_10_17116_terarkh2016881035_41 crossref_primary_10_1016_j_it_2018_11_002 crossref_primary_10_1155_2019_7495629 crossref_primary_10_1038_s41392_024_01755_x crossref_primary_10_4161_epi_24234 crossref_primary_10_1039_C4FO00803K crossref_primary_10_1016_j_tem_2009_10_002 crossref_primary_10_1111_dom_12688 crossref_primary_10_1080_15592294_2023_2201714 crossref_primary_10_1016_S0001_4079_19_32060_6 crossref_primary_10_1371_journal_pone_0143814 crossref_primary_10_1186_s12933_024_02195_1 crossref_primary_10_1016_j_celrep_2020_107548 crossref_primary_10_1016_j_lfs_2015_02_022 crossref_primary_10_1111_cge_12121 crossref_primary_10_1371_journal_pone_0015960 crossref_primary_10_1038_srep40544 crossref_primary_10_1161_ATVBAHA_124_321446 crossref_primary_10_1016_j_jdiacomp_2018_01_015 crossref_primary_10_1007_s00018_014_1816_8 |
Cites_doi | 10.1161/01.CIR.0000124061.78478.94 10.1056/NEJMoa0802987 10.1084/jem.20081188 10.1038/nature01550 10.1038/nature04853 10.1016/j.cell.2004.12.012 10.2337/diabetes.54.3.830 10.1056/NEJMoa0802743 10.1016/j.molcel.2007.02.023 10.1001/jama.290.16.2159 10.1016/j.cell.2006.03.027 10.1056/NEJMoa0806470 10.1038/ncb1546 10.1016/S1097-2765(01)00405-1 10.1038/nsmb0407-252 10.1038/nature04020 10.1161/CIRCRESAHA.108.175190 10.1038/nature01378 10.1161/01.RES.0000266449.37396.1f 10.1073/pnas.87.1.404 10.1016/j.cell.2006.04.003 10.1681/ASN.2005010013 10.1038/nature04433 10.1056/NEJMoa052187 10.1093/hmg/ddh032 10.1073/pnas.1834876100 10.1016/j.molcel.2006.12.014 10.1056/NEJMe0807625 10.1161/CIRCRESAHA.108.184358 10.1161/01.CIR.0000021122.63813.32 10.1055/s-0029-1210861 10.1007/BF02341509 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS COPYRIGHT 2009 American Diabetes Association Copyright American Diabetes Association May 2009 2009 by the American Diabetes Association. 2009 |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: COPYRIGHT 2009 American Diabetes Association – notice: Copyright American Diabetes Association May 2009 – notice: 2009 by the American Diabetes Association. 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8GL 3V. 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 LK8 M0R M0S M1P M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U S0X 7X8 5PM |
DOI | 10.2337/db08-1666 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: High School ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Consumer Health Database Health & Medical Collection (Alumni Edition) Medical Database Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 1236 |
ExternalDocumentID | PMC2671038 1777478541 A199463983 19208907 21457652 10_2337_db08_1666 diabetes_58_5_1229 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States United Kingdom--UK |
GeographicLocations_xml | – name: United States – name: United Kingdom--UK |
GroupedDBID | - 08R 0R 1AW 29F 2WC 3V. 4.4 53G 55 5GY 5RE 5RS 5VS 7RV 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAQQT AAWTL AAYEP AAYJJ ABFLS ABOCM ABPTK ABUWG ACDCL ACGOD ACPRK ADACO ADBBV ADBIT AENEX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBAFP BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EX3 F5P FRP FYUFA GICCO GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ H~9 IAG IAO IEA IHR INH INR IOF IPO K-O K9- KM KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5 M7P MBDVC O0- O5R O5S O9- OB3 OBH OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI WH7 WOQ WOW X7M XZ ZA5 ZY1 --- .55 .GJ .XZ 08P 0R~ 18M 354 6PF AAFWJ AAKAS AAYOK AAYXX ACGFO ADGHP ADZCM AEGXH AERZD AIAGR AIZAD ALIPV BTFSW CCPQU CITATION EMOBN HMCUK HZ~ ITC K2M M5~ N4W NAPCQ OHH PHGZM PHGZT TEORI TR2 UKHRP VVN W8F YFH YHG YOC ~KM 1CY 8F7 AFFNX AI. IQODW J5H MVM PJZUB PPXIY PQGLB VH1 XOL YQJ ZGI ZXP CGR CUY CVF ECM EIF NPM PMFND 7XB 8FK K9. PKEHL Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c643t-ceb29ce21a2bef380682fb01918c65218365a21968be5004d4e53c014c9131e63 |
IEDL.DBID | 7X7 |
ISSN | 0012-1797 1939-327X |
IngestDate | Thu Aug 21 14:27:02 EDT 2025 Thu Jul 10 22:24:57 EDT 2025 Fri Jul 25 10:44:51 EDT 2025 Tue Jun 17 21:57:39 EDT 2025 Thu Jun 12 23:57:54 EDT 2025 Tue Jun 10 20:58:34 EDT 2025 Fri Jun 27 05:16:43 EDT 2025 Tue Jun 10 19:56:16 EDT 2025 Mon Jul 21 05:16:43 EDT 2025 Mon Jul 21 09:14:19 EDT 2025 Thu Apr 24 22:53:30 EDT 2025 Tue Jul 01 03:04:01 EDT 2025 Fri Jan 15 19:45:48 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Endocrinopathy Hyperglycemia Gene Enzyme Lysine Aminoacid Diabetes mellitus Tail Epigenetics Histone |
Language | English |
License | CC BY 4.0 Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c643t-ceb29ce21a2bef380682fb01918c65218365a21968be5004d4e53c014c9131e63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC2671038 |
PMID | 19208907 |
PQID | 216491219 |
PQPubID | 34443 |
PageCount | 8 |
ParticipantIDs | crossref_citationtrail_10_2337_db08_1666 gale_infotracgeneralonefile_A199463983 pubmed_primary_19208907 gale_incontextgauss_8GL_A199463983 proquest_miscellaneous_67179326 proquest_journals_216491219 gale_infotracmisc_A199463983 gale_infotracacademiconefile_A199463983 highwire_diabetes_diabetes_58_5_1229 pascalfrancis_primary_21457652 gale_incontextcollege_GICCO_A199463983 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2671038 crossref_primary_10_2337_db08_1666 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-05-01 |
PublicationDateYYYYMMDD | 2009-05-01 |
PublicationDate_xml | – month: 05 year: 2009 text: 2009-05-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2009 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Nathan (2022031209283954800_B2) 2005; 353 Wang (2022031209283954800_B14) 2001; 8 Reddy (2022031209283954800_B26) 2008; 103 Trojer (2022031209283954800_B18) 2006; 125 Lake (2022031209283954800_B32) 1988; 31 Lan (2022031209283954800_B23) 2007; 26 Kennedy (2022031209283954800_B28) 2005; 54 Candido (2022031209283954800_B11) 2002; 106 Klose (2022031209283954800_B24) 2006; 442 Mack (2022031209283954800_B8) 2008; 103 Gerstein (2022031209283954800_B6) 2008; 358 Metzger (2022031209283954800_B19) 2005; 437 Candido (2022031209283954800_B29) 2004; 109 Akagi (2022031209283954800_B10) 2003; 100 Thomas (2022031209283954800_B12) 2005; 16 Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2022031209283954800_B1) 2003; 290 Chalmers (2022031209283954800_B4) 2008; 359 Hartmann (2022031209283954800_B31) 1989; 93 Shi (2022031209283954800_B16) 2003; 422 Holman (2022031209283954800_B30) 2008; 359 Wissmann (2022031209283954800_B21) 2007; 9 Hsueh (2022031209283954800_B27) 2007; 100 Shi (2022031209283954800_B20) 2004; 119 El-Osta (2022031209283954800_B3) 2008; 205 Roy (2022031209283954800_B7) 1990; 87 Yamane (2022031209283954800_B25) 2006; 125 Patel (2022031209283954800_B5) 2008; 358 Xiao (2022031209283954800_B13) 2003; 421 Tsukada (2022031209283954800_B22) 2006; 439 Okabe (2022031209283954800_B9) 2004; 13 Ruthenburg (2022031209283954800_B15) 2007; 25 Metzger (2022031209283954800_B17) 2007; 14 12700765 - Nature. 2003 Apr 17;422(6933):735-8 2528469 - Exp Clin Endocrinol. 1989 May;93(2-3):225-30 16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53 18796642 - Circ Res. 2008 Sep 12;103(6):568-70 16630806 - Cell. 2006 Apr 21;125(2):213-7 3138150 - Diabetologia. 1988 Jun;31(6):390-4 12105166 - Circulation. 2002 Jul 9;106(2):246-53 15023892 - Circulation. 2004 Mar 30;109(12):1536-42 17525381 - Circ Res. 2007 May 25;100(10):1415-27 18809715 - J Exp Med. 2008 Sep 29;205(10):2409-17 18843126 - N Engl J Med. 2008 Oct 9;359(15):1618-20 16079795 - Nature. 2005 Sep 15;437(7057):436-9 16603237 - Cell. 2006 May 5;125(3):483-95 18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59 12540855 - Nature. 2003 Feb 6;421(6923):652-6 15620353 - Cell. 2004 Dec 29;119(7):941-53 17410086 - Nat Struct Mol Biol. 2007 Apr;14(4):252-4 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89 16362057 - Nature. 2006 Feb 16;439(7078):811-6 18688044 - Circ Res. 2008 Sep 12;103(6):615-23 11779497 - Mol Cell. 2001 Dec;8(6):1207-17 16107577 - J Am Soc Nephrol. 2005 Oct;16(10):2976-84 17434129 - Mol Cell. 2007 Apr 13;26(1):89-101 18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72 2296596 - Proc Natl Acad Sci U S A. 1990 Jan;87(1):404-8 14597713 - Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13567-72 17218268 - Mol Cell. 2007 Jan 12;25(1):15-30 16732292 - Nature. 2006 Jul 20;442(7100):312-6 14681297 - Hum Mol Genet. 2004 Feb 1;13(3):285-93 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53 14570951 - JAMA. 2003 Oct 22;290(16):2159-67 15734862 - Diabetes. 2005 Mar;54(3):830-7 |
References_xml | – volume: 109 start-page: 1536 year: 2004 ident: 2022031209283954800_B29 article-title: Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis publication-title: Circulation doi: 10.1161/01.CIR.0000124061.78478.94 – volume: 358 start-page: 2560 year: 2008 ident: 2022031209283954800_B5 article-title: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0802987 – volume: 205 start-page: 2409 year: 2008 ident: 2022031209283954800_B3 article-title: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia publication-title: J Exp Med doi: 10.1084/jem.20081188 – volume: 422 start-page: 735 year: 2003 ident: 2022031209283954800_B16 article-title: Coordinated histone modifications mediated by a CtBP co-repressor complex publication-title: Nature doi: 10.1038/nature01550 – volume: 442 start-page: 312 year: 2006 ident: 2022031209283954800_B24 article-title: The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36 publication-title: Nature doi: 10.1038/nature04853 – volume: 119 start-page: 941 year: 2004 ident: 2022031209283954800_B20 article-title: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 publication-title: Cell doi: 10.1016/j.cell.2004.12.012 – volume: 54 start-page: 830 year: 2005 ident: 2022031209283954800_B28 article-title: Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? publication-title: Diabetes doi: 10.2337/diabetes.54.3.830 – volume: 358 start-page: 2545 year: 2008 ident: 2022031209283954800_B6 article-title: Effects of intensive glucose lowering in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0802743 – volume: 26 start-page: 89 year: 2007 ident: 2022031209283954800_B23 article-title: S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription publication-title: Mol Cell doi: 10.1016/j.molcel.2007.02.023 – volume: 290 start-page: 2159 year: 2003 ident: 2022031209283954800_B1 article-title: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy publication-title: JAMA doi: 10.1001/jama.290.16.2159 – volume: 125 start-page: 483 year: 2006 ident: 2022031209283954800_B25 article-title: JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor publication-title: Cell doi: 10.1016/j.cell.2006.03.027 – volume: 359 start-page: 1577 year: 2008 ident: 2022031209283954800_B30 article-title: 10-year follow-up of intensive glucose control in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa0806470 – volume: 9 start-page: 347 year: 2007 ident: 2022031209283954800_B21 article-title: Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression publication-title: Nat Cell Biol doi: 10.1038/ncb1546 – volume: 8 start-page: 1207 year: 2001 ident: 2022031209283954800_B14 article-title: Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase publication-title: Mol Cell doi: 10.1016/S1097-2765(01)00405-1 – volume: 14 start-page: 252 year: 2007 ident: 2022031209283954800_B17 article-title: The expanding world of histone lysine demethylases publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb0407-252 – volume: 437 start-page: 436 year: 2005 ident: 2022031209283954800_B19 article-title: LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription publication-title: Nature doi: 10.1038/nature04020 – volume: 103 start-page: 615 year: 2008 ident: 2022031209283954800_B26 article-title: Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.175190 – volume: 421 start-page: 652 year: 2003 ident: 2022031209283954800_B13 article-title: Structure and catalytic mechanism of the human histone methyltransferase SET7/9 publication-title: Nature doi: 10.1038/nature01378 – volume: 100 start-page: 1415 year: 2007 ident: 2022031209283954800_B27 article-title: Recipes for creating animal models of diabetic cardiovascular disease publication-title: Circ Res doi: 10.1161/01.RES.0000266449.37396.1f – volume: 87 start-page: 404 year: 1990 ident: 2022031209283954800_B7 article-title: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.87.1.404 – volume: 125 start-page: 213 year: 2006 ident: 2022031209283954800_B18 article-title: Histone lysine demethylases and their impact on epigenetics publication-title: Cell doi: 10.1016/j.cell.2006.04.003 – volume: 16 start-page: 2976 year: 2005 ident: 2022031209283954800_B12 article-title: Interactions between renin angiotensin system and advanced glycation in the kidney publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005010013 – volume: 439 start-page: 811 year: 2006 ident: 2022031209283954800_B22 article-title: Histone demethylation by a family of JmjC domain-containing proteins publication-title: Nature doi: 10.1038/nature04433 – volume: 353 start-page: 2643 year: 2005 ident: 2022031209283954800_B2 article-title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa052187 – volume: 13 start-page: 285 year: 2004 ident: 2022031209283954800_B9 article-title: Limited capacity of the nuclear matrix to bind telomere repeat binding factor TRF1 may restrict the proliferation of mortal human fibroblasts publication-title: Hum Mol Genet doi: 10.1093/hmg/ddh032 – volume: 100 start-page: 13567 year: 2003 ident: 2022031209283954800_B10 article-title: Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1834876100 – volume: 25 start-page: 15 year: 2007 ident: 2022031209283954800_B15 article-title: Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark publication-title: Mol Cell doi: 10.1016/j.molcel.2006.12.014 – volume: 359 start-page: 1618 year: 2008 ident: 2022031209283954800_B4 article-title: UKPDS and the legacy effect publication-title: N Engl J Med doi: 10.1056/NEJMe0807625 – volume: 103 start-page: 568 year: 2008 ident: 2022031209283954800_B8 article-title: An epigenetic clue to diabetic vascular disease publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.184358 – volume: 106 start-page: 246 year: 2002 ident: 2022031209283954800_B11 article-title: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice publication-title: Circulation doi: 10.1161/01.CIR.0000021122.63813.32 – volume: 93 start-page: 225 year: 1989 ident: 2022031209283954800_B31 article-title: Spontaneous recovery of streptozotocin diabetes in mice publication-title: Exp Clin Endocrinol doi: 10.1055/s-0029-1210861 – volume: 31 start-page: 390 year: 1988 ident: 2022031209283954800_B32 article-title: In vivo assessment of isolated pancreatic islet viability using the streptozotocin-induced diabetic nude rat publication-title: Diabetologia doi: 10.1007/BF02341509 – reference: 17525381 - Circ Res. 2007 May 25;100(10):1415-27 – reference: 16732292 - Nature. 2006 Jul 20;442(7100):312-6 – reference: 17434129 - Mol Cell. 2007 Apr 13;26(1):89-101 – reference: 14570951 - JAMA. 2003 Oct 22;290(16):2159-67 – reference: 17410086 - Nat Struct Mol Biol. 2007 Apr;14(4):252-4 – reference: 16362057 - Nature. 2006 Feb 16;439(7078):811-6 – reference: 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53 – reference: 17218268 - Mol Cell. 2007 Jan 12;25(1):15-30 – reference: 16603237 - Cell. 2006 May 5;125(3):483-95 – reference: 18688044 - Circ Res. 2008 Sep 12;103(6):615-23 – reference: 15023892 - Circulation. 2004 Mar 30;109(12):1536-42 – reference: 12105166 - Circulation. 2002 Jul 9;106(2):246-53 – reference: 18539917 - N Engl J Med. 2008 Jun 12;358(24):2545-59 – reference: 18539916 - N Engl J Med. 2008 Jun 12;358(24):2560-72 – reference: 16630806 - Cell. 2006 Apr 21;125(2):213-7 – reference: 3138150 - Diabetologia. 1988 Jun;31(6):390-4 – reference: 2528469 - Exp Clin Endocrinol. 1989 May;93(2-3):225-30 – reference: 16107577 - J Am Soc Nephrol. 2005 Oct;16(10):2976-84 – reference: 16079795 - Nature. 2005 Sep 15;437(7057):436-9 – reference: 12540855 - Nature. 2003 Feb 6;421(6923):652-6 – reference: 15620353 - Cell. 2004 Dec 29;119(7):941-53 – reference: 18784090 - N Engl J Med. 2008 Oct 9;359(15):1577-89 – reference: 2296596 - Proc Natl Acad Sci U S A. 1990 Jan;87(1):404-8 – reference: 18796642 - Circ Res. 2008 Sep 12;103(6):568-70 – reference: 16371630 - N Engl J Med. 2005 Dec 22;353(25):2643-53 – reference: 18809715 - J Exp Med. 2008 Sep 29;205(10):2409-17 – reference: 14597713 - Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13567-72 – reference: 12700765 - Nature. 2003 Apr 17;422(6933):735-8 – reference: 14681297 - Hum Mol Genet. 2004 Feb 1;13(3):285-93 – reference: 15734862 - Diabetes. 2005 Mar;54(3):830-7 – reference: 18843126 - N Engl J Med. 2008 Oct 9;359(15):1618-20 – reference: 11779497 - Mol Cell. 2001 Dec;8(6):1207-17 |
SSID | ssj0006060 |
Score | 2.4918358 |
Snippet | Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating
Epigenetic Marks That Coexist on the... Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) Study and more... OBJECTIVE--Results from the Diabetes Control Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC)... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1229 |
SubjectTerms | Amino acids Animals Biological and medical sciences Cattle Complications and side effects Diabetes Diabetes. Impaired glucose tolerance Diabetic Angiopathies - genetics DNA binding proteins DNA Methylation DNA Primers DNA, Complementary - genetics Endocrine pancreas. Apud cells (diseases) Endocrinopathies Endothelium, Vascular - physiology Enzymes Epidemiology Epigenetics Etiopathogenesis. Screening. Investigations. Target tissue resistance Genetic aspects Genetic Predisposition to Disease Genetic transcription Glucose Histone-Lysine N-Methyltransferase - genetics Histone-Lysine N-Methyltransferase - metabolism Humans Hyperglycemia Hyperglycemia - complications Hyperglycemia - enzymology Hyperglycemia - genetics Hyperglycemia - pathology Lysine - metabolism Medical sciences Methyltransferases Original Peptides Physiological aspects Proteins Reverse Transcriptase Polymerase Chain Reaction RNA - genetics RNA - isolation & purification Transcription (Genetics) |
Title | Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail |
URI | http://diabetes.diabetesjournals.org/content/58/5/1229.abstract https://www.ncbi.nlm.nih.gov/pubmed/19208907 https://www.proquest.com/docview/216491219 https://www.proquest.com/docview/67179326 https://pubmed.ncbi.nlm.nih.gov/PMC2671038 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgV0JcEG_KLsVCq4VLtI6d5wkt3S4V2i4IdUVvluM4baU2KU16KH-JP8lMXiWo4lK18ii1PZ7JN_b4G0LOHMExFwFiE8Niy_EVbjRpZTFuROQlseBlbcDxrTe6c75M3Wmdm5PXaZWNTywddZxp3CO_4IDrQxvs6-P6p4VFo_Bwta6gcZ8cI3MZZnT50zbeYoDNqxsoNkcWTr8iFuJC-BdxhKymXsmNuH8dNU65YQrGREmVw1wlVZGLQyj032TKv95O14_JoxpW0stqHTwh90z6lDwY1wfnz8jvEcSbm9lyp81qoSgW7AAHQRW9qirS00GWrc2mriVBs4SW_CGpoWMDqgSIbahKY3plVu3vYfprt4KHNBo2Mf2xKOYUmaytS13VTUtndLhGxk-8LEnxZlBOJ3NVwB8iCWdBs5QCBqU3O0zApxO1WD4nd9fDyWBk1XUaLA14prA0ROehNtxWPDKJCJgX8CQC7GgH2nMRg3muAs15QWRcMMrYMa7QEJvp0Ba28cQLcpTCiF4RGhuG6W-OZiJ04pgrzbQfGQVAIrEZUz3yoVGX1DWJOdbSWEoIZlCzEjUrUbM98q4VXVfMHYeEzlHnEpkwUky10dV2jYTxDb5K5AR2AMMFAp7WFZypbZ7L4PNNR-h9LZRk0Cut6isOMDZk2epInnckZxXH-CHB044gGL_uNJ81i1U2m_X7L24gXWlzHvZIv7OQ2wlBnnofdNQjJ83KlrUTy2Vrcj3ytm3FDmBeXmqybS49Hx08h3l8WVnBfqpDzoKQ-T3id-yjFUBe825LupiX_OYcnspE8Pq_fTohD6uDPcw9PSVHxWZr3gA-LKJ-6QXgMxjYfXL8aXj77fsfkvdptg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviG_KxmahMXiJltj5fEBotB0dawtCndibcRynrdQmpWmFyr-E-B-5az5K0MTb3lr55Ni-8_nOvvsdIUc2ZxiLAL6JNiPD9iReNClpmEzz0I0jzja1AfsDt3tpf7xyrnbI7zIXBsMqS524UdRRqvCO_ISBXR9YsL_ezb8bWDQKH1fLChq5VFzo9Q_w2LK3521g7yvGzjrDVtcoigoYCg7fpaHAlQyUZpZkoY65b7o-i0MwdCxfuQ4aDK4j4TOuH2oHJCiytcMVOBIqsLilXQ793iK7NgdPpkF233cGn79Uqh-8gTznxWKI--nlUEaMc-8kChFH1d2gMW4PwPIYKLGJMTRTZsCdOC-rcZ3d-2_45l_n4dl9cq8wZOlpLnkPyI5OHpLb_eKp_hH51QUPdzGarpWeTSTFEiGgkqik7XUiZxNFW2k614uiegVNY7pBLEk07WsQHjDqNZVJRNt6Vv3vJD_XM-iklCkd0a-T5ZgidrZxqvJKbcmIduaIMYrpmRRzkTI6HMslfBBhP5c0TShYvbS3xpB_OpST6WNyeSNMfEIaCczoGaGRNjHgzlYmD-woYlKZygu1BNMltkxTNsmbkl1CFbDpWL1jKsB9Qs4K5KxAzjbJy4p0nmOFXEd0jDwXiL2RYHCPyi-IBMyv9UkgCrENVqPPobc64Uiuskz4H3o1otcFUZzCqJQskipgbojrVaM8rlGOclTz6wj3a4SgblSt-agUVlE-D2x_OL5whMVY0CQHNUGuFgSR8T3gUZPslZItCrWZiWqTN8lh1YoDwEjARKerTLgeHikM1vFpvgu2Sx0w0w9Mr0m82v6oCBBJvd6STMYbRHUGvZrcf_7fMR2SO91hvyd654OLPXI3f1bEyNd90lguVvoFWKfL8KDQCZR8u2k19Afio6Ou |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKkSouiDehpbVQKVxW2bX3eUCoyoOUJoVDKnpzvV5vEinZDdlEKPwlfgH_jpnsIyyKuPWWyCOv7RmPZ-yZbwg5tTnDWATwTbQZGbYn8aJJScNkmoduHHG2qQ04uHJ71_bnG-dmj_wuc2EwrLLUiRtFHaUK78ibDOz6wIL91YyLqIiv7e7H-XcDC0jhQ2tZTSOXkEu9_gHeW_bhog2sfstYtzNs9YyiwICh4CBeGgrcykBpZkkW6pj7puuzOASjx_KV66Dx4DoSPun6oXZAmiJbO1yBU6ECi1va5dDvPXLf446FW8y7qXw9E_yCPPvFYogA6uWgRoxzrxmFiKjqbnAZt0dheSCUKMUYpCkz4FOcF9jYZQH_G8j518nYfUQeFiYtPc9l8DHZ08kTcjAoHu2fkl898HUXo-la6dlEUiwWAsqJStpeJ3I2UbSVpnO9KOpY0DSmG-ySRNOBBjEC815TmUS0rWfV_07ycz2DTkrp0hH9NlmOKaJoG-cqr9mWjGhnjmijmKhJMSspo8OxXMIHEQB0SdOEgv1L-2sM_qdDOZk-I9d3wsLnZD-BGb0kNNImht7ZyuSBHUVMKlN5oZZgxMSWacoGeV-yS6gCQB3reEwFOFLIWYGcFcjZBnlTkc5z1JBdRGfIc4EoHAkKtMqvigTMr_VFIB6xDfajz6G3OuFIrrJM-J_6NaJ3BVGcwqiULNIrYG6I8FWjPKtRjnJ8812ERzVCUDyq1nxaCqsoHwq2PxxfOMJiLGiQ45ogVwuCGPke8KhBDkvJFoUCzUS13RvkpGrFAWBMYKLTVSZcDw8XBuv4It8F26UOmOkHptcgXm1_VASIqV5vSSbjDbY6g15N7r_675hOyAEoH9G_uLo8JA_y90UMgT0i-8vFSr8GM3UZHm8UAiW3d62B_gCLd6Z- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperglycemia+Induces+a+Dynamic+Cooperativity+of+Histone+Methylase+and+Demethylase+Enzymes+Associated+With+Gene-Activating+Epigenetic+Marks+That+Coexist+on+the+Lysine+Tail&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Brasacchio%2C+Daniella&rft.au=Okabe%2C+Jun&rft.au=Tikellis%2C+Christos&rft.au=Balcerczyk%2C+Aneta&rft.date=2009-05-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=58&rft.issue=5&rft.spage=1229&rft_id=info:doi/10.2337%2Fdb08-1666&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1777478541 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |